drugset / Trial / NCT00935831
Single Dose Safety Study for Compound to Treat Anemia in Patients With Renal Impairment
RandomizedCrossoverSingle-blindBasic science
Summary
The purpose of this study is to characterize the safety and tolerability of single doses of compound 1278863A in subjects with renal impairment.
Timeline
- Start
- 2009-08-12
- Primary completion
- 2010-04-27
- Completion
- 2010-04-27
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | GSK1278863A | Small molecule | 50 mg | Oral |
| Subject | GSK1278863A | Small molecule | 150 mg | Oral |